Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04355650 · ClinicalTrials.gov registry record · NA
Augmented Human Intelligence in Major Depressive Disorder
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 126
- Enrollment target
NCT04355650: Completed NA study, sponsored by Mayo Clinic.
NCT04355650 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 126 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04355650, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 126 participants
- Enrollment target
Study Summary
Researchers are testing whether a computer program (called a clinical decision support tool) can help clinicians predict how a patient with depression will respond to antidepressant medication.
Interventions
- OTHER Clinical decision support tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2020-01-27 |
| Est. Completion | 2022-12-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04355650
The ClinicalTrials.gov registry entry for NCT04355650 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Clinical decision support tool is the first listed.
NCT04355650 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04355650 about?
NCT04355650 is a clinical study titled "Augmented Human Intelligence in Major Depressive Disorder". Researchers are testing whether a computer program (called a clinical decision support tool) can help clinicians predict how a patient with depression will respond to antidepressant medication.
What is the current status of trial NCT04355650?
This trial is currently completed. It is a NA study. The enrollment target is 126 participants. The study started on 2020-01-27. Estimated completion is 2022-12-02.
What interventions are being tested in trial NCT04355650?
The interventions under investigation include: Clinical decision support tool (OTHER).
Who is sponsoring clinical trial NCT04355650?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.